HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
38 hedge funds and large institutions have $10.7M invested in HOOKIPA Pharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
700% more call options, than puts
Call options by funds: $48K | Put options by funds: $6K
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
18.29% more ownership
Funds ownership: 37.06% → 55.35% (+18%)
9% more funds holding
Funds holding: 35 → 38 (+3)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
47% less capital invested
Capital invested by funds: $20.2M → $10.7M (-$9.47M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$161K |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$73.4K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$66.6K |
| 4 |
Morgan Stanley
New York
|
+$55.4K |
| 5 |
Millennium Management
New York
|
+$47.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$566K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$164K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$75K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$71K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$13.1K |
HOOK Hedge Fund Activity: Q4 2024 in Review
38 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2024, worth a combined $10.7M — down 47% from $20.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new HOOK positions and 5 closed out — a net gain of 3 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Squarepoint, opening a new position worth an estimated $161K. The largest seller was EcoR1 Capital, cutting an estimated $566K.
- 38 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2024, up from 35 in Q3 2024.
- Funds reported $10.7M of HOOKIPA Pharma stock for Q4 2024, down 47% quarter-over-quarter.
- 8 funds opened new HOOKIPA Pharma positions in Q4 2024 and 5 closed out, a net change of +3 holders.
- The largest HOOKIPA Pharma buyer in Q4 2024 was Squarepoint, an estimated $161K added.
- The largest HOOKIPA Pharma seller in Q4 2024 was EcoR1 Capital, an estimated $566K sold.
Based on aggregated 13F filings for Q4 2024.